Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.38 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11394570 | 0.87 | LOXL2 (0.47) | SNCAPOLBCYP1A2ALOX15ALOX12 | |
| SCHEMBL3890238 | 0.86 | POLB (0.49) | SNCAPOLBCYP1A2SMN1; SMN2ALOX15 | |
| SCHEMBL26979837 | 0.85 | TSHR (0.40) | SNCAPOLBSMN1; SMN2ALOX15ALOX12 | |
| SCHEMBL1117240 | 0.84 | TSHR (0.50) | SNCAPOLBCYP1A2SMN1; SMN2ALDH1A1 | |
| SCHEMBL28114907 | 0.83 | CYP1A2 (0.56) | SNCAPOLBCYP1A2PDK1ALDH1A1 | |
| SCHEMBL14713516 | 0.82 | TDP1 (0.52) | SNCAPOLBCYP1A2ALOX15ALOX12 | |
| SCHEMBL30385788 | 0.81 | ALDH1A1 (0.47) | SNCAPOLBSMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL29561732 | 0.81 | S100A4 (0.46) | SNCACYP1A2ALOX15ALOX12PDK1 | |
| SCHEMBL136817 | 0.81 | CYP1A2 (0.62) | CYP1A2SMN1; SMN2ALDH1A1TSHRMAPT | |
| SCHEMBL3073523 | 0.81 | ALDH1A1 (0.47) | SNCAPOLBSMN1; SMN2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117820124-A | Method for generating 4-trifluoromethyl aniline based on microchannel reaction | 盐城师范学院 | 2024-04-05 | — | — | CN | disclosed |
| US-20090042235-A1 | PHOTOREGULATED PEPTIDE, AND METHOD FOR REGULATION OF PEPTIDE-PROTEIN COMPLEX FORMATION USING THE PHOTOREGULATED PEPTIDE | SHIMADZU CORPORATION (JP) | 2009-02-12 | — | — | US | disclosed |
| US-20090042235-A1 | PHOTOREGULATED PEPTIDE, AND METHOD FOR REGULATION OF PEPTIDE-PROTEIN COMPLEX FORMATION USING THE PHOTOREGULATED PEPTIDE | SHIMADZU CORPORATION (JP) | 2009-02-12 | — | — | US | disclosed |
| US-20090042235-A1 | PHOTOREGULATED PEPTIDE, AND METHOD FOR REGULATION OF PEPTIDE-PROTEIN COMPLEX FORMATION USING THE PHOTOREGULATED PEPTIDE | SHIMADZU CORPORATION (JP) | 2009-02-12 | — | — | US | disclosed |
| US-7029655-B2 | Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2006-04-18 | — | — | US | disclosed |
| WO-2002028441-A9 | MAGNETIC RESONANCE IMAGING AGENTS FOR IN VIVO LABELING AND DETECTION OF AMYLOID DEPOSITS | CALIFORNIA INST OF TECHN (US) | 2003-02-20 | — | — | WO | disclosed |
| US-20020098153-A1 | Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2002-07-25 | — | — | US | disclosed |
| WO-2002028441-A2 | MAGNETIC RESONANCE IMAGING AGENTS FOR IN VIVO LABELING AND DETECTION OF AMYLOID DEPOSITS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2002-04-11 | — | — | WO | disclosed |
| US-5100985-A | 1,4-bis(4-arylbutadienyl) benzenes exhibiting nonlinear optical response | HOECHST CELANESE CORP. (US) | 1992-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042235-A1 | PHOTOREGULATED PEPTIDE, AND METHOD FOR REGULATION OF PEPTIDE-PROTEIN COMPLEX FORMATION USING THE PHOTOREGULATED PEPTIDE | PTMS, DCLRE1A, CLTA | SNCA 4722/4885POLB 3641/4885CYP1A2 4843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.